(Q38169066)

30 August 2017

Lessons from ECLIPSE: a review of COPD biomarkers (English)

1 reference

30 August 2017

0 references

Rosa Faner

1

0 references

Jørgen Vestbo

object named as

Jørgen Vestbo

5

0 references

William MacNee

object named as

William MacNee

6

0 references

Ruth Tal-Singer

2

object named as

Ruth Tal-Singer

1 reference

30 August 2017

16

Emiel F M Wouters

1 reference

30 August 2017

John H Riley

3

1 reference

30 August 2017

Bartolomé Celli

4

1 reference

30 August 2017

Per Bakke

7

1 reference

30 August 2017

Peter M A Calverley

8

1 reference

30 August 2017

Harvey Coxson

9

1 reference

30 August 2017

Courtney Crim

10

1 reference

30 August 2017

Lisa D Edwards

11

1 reference

30 August 2017

Nick Locantore

12

1 reference

30 August 2017

David A Lomas

13

1 reference

30 August 2017

Bruce E Miller

14

1 reference

30 August 2017

Stephen I Rennard

15

1 reference

30 August 2017

Julie C Yates

17

1 reference

30 August 2017

Edwin K Silverman

18

1 reference

30 August 2017

Alvar Agusti

19

1 reference

30 August 2017

ECLIPSE Study Investigators

20

1 reference

30 August 2017

language of work or name

English

0 references

publication date

5 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

69

1 reference

30 August 2017

7

1 reference

30 August 2017

666-672

1 reference

Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils

30 August 2017

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

The COPD Biomarker Qualification Consortium (CBQC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Dysregulated adipokine metabolism in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Vitamin D, vitamin D binding protein, lung function and structure in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Candidate genes for COPD in two large data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Lung function in type 2 diabetes: the Normative Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genetic epidemiology of COPD (COPDGene) study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genome-wide association study of smoking behaviours in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Variants in FAM13A are associated with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genome-wide association study identifies five loci associated with lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Application of homozygosity haplotype analysis to genetic mapping with high-density SNP genotype data

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Identification of FGF7 as a novel susceptibility locus for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genome-wide association analysis of body mass in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Interleukin-18 production and pulmonary function in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Genetics of sputum gene expression in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Elevated airway purines in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Metabolic profiling detects biomarkers of protein degradation in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Evaluation of exhaled breath condensate pH as a biomarker for COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2013-204778

10.1136/THORAXJNL-2013-204778

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference